Photo: Getty Images
Here's today's feel-good story:
A new way to approach the treatment of severe asthma has been uncovered.
Researchers at the School of Biochemistry and Immunology at the Trinity Biomedical Sciences Institute (TBSI) in Ireland hope this will pave the way for effective new treatments.
“We have found that a molecule made by our own bodies, called Itaconate, can suppress key events that promote asthma by targeting an important immune protein called JAK1. By shutting off JAK1 we have shown remarkable efficacy in lab-based models of asthma.” said Luke O’Neill, lead investigator and Professor of Biochemistry at Trinity.